succinylcholine has been researched along with clonidine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Walland, A | 1 |
Böhrer, H; Martin, E; Polarz, H; Völcker, HE; Wolfrum, J | 1 |
Mohs, AJ; Peace, MR; Poklis, A; Poklis, JL; Wolf, CE | 1 |
1 review(s) available for succinylcholine and clonidine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for succinylcholine and clonidine
Article | Year |
---|---|
Oral clonidine premedication prevents the rise in intraocular pressure following succinylcholine administration.
Topics: Administration, Oral; Aged; Blood Pressure; Clonidine; Clorazepate Dipotassium; Double-Blind Method; Female; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Premedication; Succinylcholine | 1993 |
4 other study(ies) available for succinylcholine and clonidine
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Clonidine inhibits electrodermal potentials induced by preganglionic stimulation.
Topics: Animals; Autonomic Fibers, Preganglionic; Cats; Clonidine; Electric Stimulation; Female; Galvanic Skin Response; Guanethidine; Hexamethonium Compounds; Male; Reserpine; Stellate Ganglion; Succinylcholine; Vagotomy | 1984 |
Identification of Drugs in Parenteral Pharmaceutical Preparations from a Quality Assurance and a Diversion Program by Direct Analysis in Real-Time AccuTOFTM-Mass Spectrometry (DART-MS).
Topics: Amides; Analgesics; Anesthetics; Baclofen; Bupivacaine; Caffeine; Chromatography, High Pressure Liquid; Clonidine; Dexamethasone; Ephedrine; Fentanyl; Heparin; Hydromorphone; Ketamine; Mass Spectrometry; Methadone; Midazolam; Morphine; Oxytocin; Parenteral Nutrition Solutions; Phenylephrine; Ropivacaine; Succinylcholine | 2016 |